Associate Professor of Medicine
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
RDr. Lindsley is an Associate Professor of Medicine at Harvard Medical School and Dana-Farber Cancer Institute, where he is Director of the Edward P. Evans Center for Myelodysplastic Syndromes and Director of Clinical Genomics in Hematologic Malignancies. He received his M.D. and Ph.D. in Immunology from Washington University School of Medicine, then completed a residency in internal medicine at Brigham and Women’s Hospital and a fellowship in oncology at the Dana-Farber Cancer Institute. He is a member of the MDS Genetics Subcommittee for the NIH National MDS Study, the laboratory working group for National Cancer (NCI) North American myeloMATCH precision medicine initiative, NHLBI Trans-Omics for Precision Medicine Steering Committee, and the International Working Group for Prognosis in MDS (IWG-PM) molecular committee. The primary focus of his laboratory is the biology and treatment of myeloid malignancies, with a specific emphasis on bone marrow transplantation and familial leukemia predisposition. His work has led to revisions of the World Health Organization (WHO) and International Consensus Classifications (ICC) of leukemia and new models for understanding MDS outcome after transplantation.
Disclosure information not submitted.
Saturday, June 17, 2023
5:00 PM – 5:15 PM East Coast USA Time
Saturday, June 17, 2023
5:30 PM – 5:45 PM East Coast USA Time